Quest Pharmatech (QPT) Financial Statements

6 Followers

Quest Pharmatech Financial Overview

Quest Pharmatech's market cap is currently C$3.38M. The company's EPS TTM is C$; its P/E ratio is 0.68; Quest Pharmatech is scheduled to report earnings on June 26, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 24	Jan 23	Jan 22	Jan 21	Jan 20
Income Statement
Total Revenue
Gross Profit	-	-	-	-	-
Operating Income	$ -1.83M	$ -3.93M	$ -790.57K	$ -1.07M	$ -13.63M
EBITDA	$ -2.99M	$ -64.85M	$ -84.99M	$ 190.11M	$ -13.20M
Net Income	$ -3.02M	$ -64.89M	$ -85.04M	$ 190.06M	$ -6.18M
Balance Sheet
Cash & Short-Term Investments	$ ―	$ ―	$ ―	$ ―	$ ―
Total Assets	$ 24.48M	$ 26.80M	$ 91.03M	$ 175.61M	$ 4.45M
Total Debt	$ 1.00M	$ 1.00M	$ 14.00K	$ 304.37K	$ 2.74M
Net Debt	$ 283.04K	$ 625.34K	$ -250.34K	$ 105.25K	$ 285.83K
Total Liabilities	$ 1.32M	$ 1.11M	$ 622.60K	$ 389.44K	$ 20.95M
Stockholders' Equity	$ ―	$ ―	$ ―	$ ―	$ ―
Cash Flow
Free Cash Flow	$ -342.42K	-	$ -170.78K	$ -2.52M	$ -6.38M
Operating Cash Flow	$ -342.42K	$ -554.68K	$ -170.78K	$ -2.52M	$ -6.38M
Investing Cash Flow
Financing Cash Flow

Quest Pharmatech Earnings and Revenue History

Income Statement >

Quest Pharmatech Debt to Assets

Balance Sheet >

Quest Pharmatech Cash Flow

Cash Flow >

Quest Pharmatech Forecast EPS vs Actual EPS

Earnings >